STIM Neuronetics, Inc. Insider Trading

10% owner Chernett Jorey bought 35,000 shares of STIM at $1.78 on 2026-07-14; stock +44.1% in 30 days, -62.3% from 52-week high.

Chernett Jorey, a 10% shareholder, purchased 35,000 shares at $1.78, bringing holdings to 10,588,988 shares. The stock has rallied +44.1% over the prior 30 days and +30.7% over 90 days from the transaction date, though it remains -62.3% below its 52-week high of $4.85. Jorey's cross-ticker track record shows 20 prior buys with an 80.00% win rate and average 90-day returns of +27.6%, but same-ticker history at STIM is limited: only 1 of 5 prior trades was measurable at the 90-day mark, returning +27.2%. The company reported $34.5M in latest-quarter revenue with -$10.8M net income and annual revenue growth of +99.2%, though the company remains unprofitable on a full-year basis. This purchase occurs as the stock recovers from depressed levels, with the insider adding to a substantial existing position.

10% Owner Chernett Jorey buys 100,000 shares of STIM at $1.17; stock down -75.5% from 52-week high, all 5 prior STIM trades unprofitable at 90-day mark

Chernett Jorey, a 10% owner, purchased 100,000 shares at $1.17 on 2026-05-19, increasing holdings from 10,453,988 to 10,553,988 shares. The stock has declined -24.7% over 30 days and trades -75.5% below its 52-week high of $4.85. More notably, Jorey's five prior purchases at STIM produced uniformly negative 90-day outcomes, with a 0 of 5 well-timed rate at the 90-day mark, suggesting a pattern of unfavorable timing at this specific ticker despite his cross-ticker track record averaging +28.6% over 90 days across 20 prior buys. The company is unprofitable (net income of $-10,790,000.00 for the latest quarter) while showing strong annual revenue growth of +99.2%, creating mixed fundamental signals that may explain continued accumulation by a significant shareholder in a depressed stock.

10% owner Chernett Jorey buys 475,000 shares at $1.34; stock now at $1.19, down 24.7% in 30 days; prior STIM buys 0 of 5 well-timed at 90d mark.

Chernett Jorey, a 10% owner, purchased 475,000 shares of Neuronetics at $1.34 on 2026-05-12, increasing holdings by 4.8% to 10.45M shares. However, the stock has declined to $1.19 (down 24.7% over 30 days and 75.5% from its 52-week high of $4.85), eroding the transaction value. More significantly, Jorey's prior five purchases at STIM show a consistent pattern of poor timing: none of the five earlier buys delivered positive 90-day returns, with losses ranging from -5.6% to -25.3% at the 90-day mark. While Jorey's cross-ticker track record shows a 60% 90-day win rate with +28.6% average return, this insider's execution at STIM has been markedly unsuccessful. The company remains unprofitable (net income $-10.8M in the latest quarter) despite 99.2% annual revenue growth, adding fundamental concern to the timing pattern.

10% owner Chernett Jorey buys 200,000 shares in 2 transactions for $309,000.00 as STIM trades -65.9% from 52-week high

Chernett Jorey, a 10% owner, executed 2 separate purchases totaling 200,000 shares for $309,000.00 at an average blended price of $1.54 on April 20-21, 2026. The timing coincides with a steep drawdown: the stock trades at $1.59 currently, down 65.9% from its 52-week high and off 27.7% over the past 90 days. Neuronetics is unprofitable (net income $-9.0M in the latest period) but growing revenue sharply (99.2% annual growth), suggesting the share price decline reflects near-term losses rather than growth concerns. Jorey's cross-ticker track record shows his prior 20 open-market buys averaged -1.5% returns over 30 days, and at this ticker specifically, 4 of his 5 prior trades remain unmeasurable in outcome; his one dated 2026-03-20 achieved a modest +0.7% 30-day return. This filing adds 200,000 shares (2.0% increase) to his position, now 9.98M shares post-transaction, representing further accumulation during an extended decline.

10% Owner Chernett Jorey purchases 500,000 shares of STIM at $1.35; stock down 72.8% from 52-week high.

Chernett Jorey, a 10% owner, purchased 500,000 shares on 2026-03-27 at $1.35, increasing holdings to 9,393,276 shares. The transaction occurred in a context of significant price weakness: the stock is down 72.8% from its 52-week high of $4.66 and has declined 5.2% in the prior 30 days. The purchase represents a $675,000 commitment to a company with $37.3M in quarterly revenue but $-9.0M net income, indicating ongoing unprofitability despite 99.2% annual revenue growth. This buy follows four other purchases at STIM within the preceding 11 days (2026-03-19 through 2026-03-26), suggesting concentrated accumulation activity by the insider during a period of market stress. The pattern and magnitude of these repeated purchases merit investor attention in the context of the company's current financial position and stock performance.

10% owner Chernett Jorey buys 385,442 shares of STIM at $1.25, accumulating to 9.78M shares amid +99.2% revenue growth but -$9.0M net income.

Chernett Jorey, holding 10% of Neuronetics, purchased 385,442 shares at $1.25 on 2026-03-30, expanding holdings by 4.1% to 9,778,988 shares. This transaction represents the most recent in a sequence of five consecutive buys at STIM spanning 2026-03-19 through 2026-03-30, indicating sustained accumulation at depressed valuations—the stock trades 72.8% below its 52-week high of $4.66 and has declined 5.2% over the past 30 days. The company's fundamentals present a mixed picture: annual revenue growth accelerated at +99.2% and the latest quarter generated $37.3M in revenue, yet the company remains unprofitable with a -$9.0M net loss over the most recent full fiscal year and a market capitalization of only $88.0M. Investors should monitor whether this pattern of sustained insider accumulation at steep discounts from recent highs reflects an opportunity to establish positions or signals unresolved operational challenges beneath the surface growth metrics.

10% owner Chernett Jorey purchases 150,000 shares ($211.0K) at $1.41 avg; stock down 72.4% from 52-week high

Chernett Jorey, a 10% owner, executed 2 purchases totaling 150,000 shares for $211,000.00 at a blended average price of $1.41 on March 25–26, 2026. The stock is currently trading at $1.29, -72.4% from its 52-week high of $4.67, and has declined 9.2% over the past 90 days. Jorey's holdings increased from 8,743,276 to 8,893,276 shares (+1.7%), maintaining a substantial 10% ownership stake. While the company reported strong annual revenue growth of +99.2% in its latest fiscal year, it remains unprofitable with net income of $-9,045,000.00 in the most recent quarter and negative full-year net income. This transaction occurs in a backdrop of significant stock price deterioration and mounting losses, leaving the purchase motivation unclear relative to the company's fundamental trajectory.

10% Owner Chernett Jorey bought 169,472 shares of STIM at $1.41 on 2026-03-20, adding to three consecutive daily purchases (2026-03-17 through 2026-03-19).

Chernett Jorey, a 10% owner of Neuronetics, made a fourth consecutive daily purchase on 2026-03-20, acquiring 169,472 shares at $1.41, boosting holdings to 8,743,276 shares. The series of same-day and consecutive-day transactions (purchases on 2026-03-17, 2026-03-18, 2026-03-19, and 2026-03-20) suggests sustained accumulation during a period when the stock traded at a significant discount: the current price of $1.60 represents -68.1% from the 52-week high of $5.01. The company reported annual revenue growth of +99.2% and generated $37,297,000 in latest-quarter revenue, but remains unprofitable with net income of $-9,045,000 over its most recent full fiscal year. Investors should note that prior trades at this ticker have no measurable 90-day outcomes, limiting visibility into whether this accumulation pattern reflects a forward-looking conviction or merely opportunistic positioning at depressed levels.

10% owner Chernett Jorey buys 1,057,400 shares (1.06M) in 2 transactions for $1,418,490.00 at avg $1.34/share

Chernett Jorey, a 10% owner of Neuronetics, purchased 1,057,400 shares across 2 separate transactions on 2026-03-18 and 2026-03-19 at a blended average price of $1.34, increasing his holdings by 14.1% to 8,573,804 shares. The company is unprofitable (net income $-9,045,000.00 over its most recent full fiscal year) and trading 71.3% below its 52-week high of $5.06, though it showed strong revenue growth of 99.2% year-over-year. A 10% owner making a material $1.4M equity purchase in a depressed stock environment merits attention, though the purchase occurred at prices well above the 52-week low of $1.22 and current market price of $1.45. His prior same-ticker history shows 2 buys (both recent), and outcomes from these purchases are not yet measurable.

10% Owner Chernett Jorey purchased 531,000 shares of STIM at $1.16 (2026-03-17), increasing stake to 7.52M shares as stock trades -73.3% from 52-week high.

Chernett Jorey, a 10% owner, purchased 531,000 shares at $1.16, expanding his holding from 6.99M shares to 7.52M shares on 2026-03-17. The company is unprofitable with net income of $-9.0M against revenue of $37.3M, though annual revenue growth stands at +99.2%. At current price of $1.35, the stock trades -73.3% from its 52-week high of $5.06, and has declined -4.9% over 30 days and -4.6% over 90 days. This insider's prior trades at STIM are not yet measurable in outcome, and his cross-ticker track record shows 10 prior buys with no measurable timing pattern at the 90-day mark, limiting inference about the conviction or timing rationale behind this accumulation in a materially depressed equity.